Led · Equity · Sep 2024

ML One develops Russian technologies for multilateral well completion that enable the deployment of lateral branches with varied functionality and constructions. The company’s solutions were introduced at its founding in 2017 and the firm says its portfolio includes more than 260 completed jobs, described as unprecedented in global practice. ML One is managed by an LLC formed in 2017. In 2023 the company reported revenue of 383.7 million rubles and a net profit of 27 million rubles. The newly raised funds will be used to purchase materials and equipment and to build inventory stocks. Ownership is split 45%/45% between Alexander Kashlev and Ivan Mnatsakanov (their stakes are pledged to several organisations, including the Moscow Venture Fund), with 5% held by Sergey Fedotov and 5% by Adala Compliance Limited (registered in Cyprus).

Led · Equity · Jan 2024

Microneedles develops and manufactures bioresorbable microneedles designed to deliver active ingredients and pharmaceutical substances into the epidermis to a controlled depth. The company launched a commercial project in 2014 and established a project company in 2015, which became a Skolkovo resident a year later. Its commercial brand BLOM markets anti‑aging microneedle patches and applicators that reduce procedure time to 20–25 minutes versus several hours for some foreign alternatives; the company has released 10 BLOM microneedle products for different facial and body zones. Microneedles has patented the microneedles themselves, its manufacturing platform, and the fabrication method, and is working to register its microneedle applicators as medical devices in the U.S. The team is testing products for postoperative skin rehabilitation after blepharoplasty and mammoplasty and plans to introduce solutions for combined dermatological protocols. Recently received investment will be used for foreign registrations, production expansion, additional patenting, and launching new products.